- Presentations
- 5
- Markets
- 1
Viread is a brand of Tenofovir disoproxil marketed by Gilead Sciences, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Tenofovir disoproxil
- Brand owner
- Gilead Sciences
- Registered in
- United States
- Strengths and forms
- 40 mg/g oral powder, 150 mg tablet, 200 mg tablet, 250 mg tablet, 300 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Viread 40 mg/g oral powderOral | Gilead Sciences | US FDA | Available on request |
| Viread 150 mg tabletOral | Gilead Sciences | US FDA | Available on request |
| Viread 200 mg tabletOral | Gilead Sciences | US FDA | Available on request |
| Viread 250 mg tabletOral | Gilead Sciences | US FDA | Available on request |
| Viread 300 mg tabletOral | Gilead Sciences | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Viread
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.